The Claim
The lipid plaque density index (LPDI), calculated as the ratio of maximum lipid core burden index within a 4-mm segment to atheroma volume, is a measurable imaging biomarker that distinguishes patients with coronary artery disease who are more likely to experience cardiovascular events based on LDL-C levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The lipid plaque density index (LPDI) is a calculated measure from medical imaging that identifies patients with coronary artery disease who have a higher likelihood of experiencing cardiovascular events, based on their LDL cholesterol levels.
See the scientific wording
The lipid plaque density index (LPDI), calculated as the ratio of maximum lipid core burden index within a 4-mm segment to atheroma volume, is a measurable imaging biomarker that distinguishes patients with coronary artery disease who are more likely to experience cardiovascular events based on LDL-C levels.
When bad cholesterol drops very low, fat inside artery walls shrinks as immune cells remove it, making the plaque harder and less likely to burst and cause a heart attack or stroke.
What the research says
1 studyThis study found that people with more fatty buildup in their arteries (measured by LPDI) are more likely to have heart problems unless their bad cholesterol (LDL) is lowered very low — so LPDI helps doctors tell who needs stronger treatment.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.